These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 18691101)

  • 1. Genetic insights into sepsis: what have we learned and how will it help?
    Wurfel MM
    Curr Pharm Des; 2008; 14(19):1900-11. PubMed ID: 18691101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The latest research advance in media involved in sepsis].
    Hao Y; Geng L
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 Feb; 28(2):188-92. PubMed ID: 26911956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic polymorphisms of innate and adaptive immunity as predictors of outcome in critically ill patients.
    Kompoti M; Michopoulos A; Michalia M; Clouva-Molyvdas PM; Germenis AE; Speletas M
    Immunobiology; 2015 Mar; 220(3):414-21. PubMed ID: 25454804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic variations and susceptibility to sepsis.
    Papathanassoglou ED; Giannakopoulou MD; Bozas E
    AACN Adv Crit Care; 2006; 17(4):394-422. PubMed ID: 17091041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detecting genetic predisposition for complicated clinical outcomes after burn injury.
    Barber RC; Chang LY; Purdue GF; Hunt JL; Arnoldo BD; Aragaki CC; Horton JW
    Burns; 2006 Nov; 32(7):821-7. PubMed ID: 17005325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sepsis and septic shock: pathophysiological and cardiovascular background as basis for therapy.
    De Kock I; Van Daele C; Poelaert J
    Acta Clin Belg; 2010; 65(5):323-9. PubMed ID: 21128559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic polymorphisms in sepsis.
    Dahmer MK; Randolph A; Vitali S; Quasney MW
    Pediatr Crit Care Med; 2005 May; 6(3 Suppl):S61-73. PubMed ID: 15857562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-10 rs2227307 and CXCR2 rs1126579 polymorphisms modulate the predisposition to septic shock.
    Cardoso CP; de Oliveira AJ; Botoni FA; Rezende IC; Alves-Filho JC; Cunha Fde Q; Estanislau Jde A; Magno LA; Rios-Santos F
    Mem Inst Oswaldo Cruz; 2015 Jun; 110(4):453-60. PubMed ID: 26038959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of tumor necrosis factor α -308G/A and interleukin-6 -174G/C gene polymorphism with pneumonia-induced sepsis.
    Feng B; Mao ZR; Pang K; Zhang SL; Li L
    J Crit Care; 2015 Oct; 30(5):920-3. PubMed ID: 26025100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular biology and immunopathogenetic mechanisms of sepsis].
    Průcha M
    Cas Lek Cesk; 2009; 148(2):86-90. PubMed ID: 19637444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The era of genomics: impact on sepsis clinical trial design.
    Cariou A; Chiche JD; Charpentier J; Dhainaut JF; Mira JP
    Crit Care Med; 2002 May; 30(5 Suppl):S341-8. PubMed ID: 12004257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic approaches to innate immunity: severe sepsis and septic shock.
    Lolis E; Bucala R
    Nat Rev Drug Discov; 2003 Aug; 2(8):635-45. PubMed ID: 12904813
    [No Abstract]   [Full Text] [Related]  

  • 13. HLA-A*31 as a marker of genetic susceptibility to sepsis.
    da Silva FP; Preuhs Filho G; Finger E; Barbeiro HV; Zampieri FG; Goulart AC; Torggler Filho F; Panajotopoulos N; Velasco IT; Kalil J; de Souza HP; da Cruz Neto LM; Rodrigues H
    Rev Bras Ter Intensiva; 2013; 25(4):284-9. PubMed ID: 24553509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [[Antithrombin III concentrates in the treatmetn of sepsis and septic shock: indictions, limits and future prospects] ].
    Baudo F; de Cataldo F
    Minerva Anestesiol; 2000 Nov; 66(11 Suppl 1):3-23. PubMed ID: 11213542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic polymorphisms in sepsis.
    Lin MT; Albertson TE
    Crit Care Med; 2004 Feb; 32(2):569-79. PubMed ID: 14758181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NKT cells: the culprits of sepsis?
    Leung B; Harris HW
    J Surg Res; 2011 May; 167(1):87-95. PubMed ID: 21035139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of hemostatic gene polymorphisms for susceptibility to and outcome of severe sepsis.
    Texereau J; Pene F; Chiche JD; Rousseau C; Mira JP
    Crit Care Med; 2004 May; 32(5 Suppl):S313-9. PubMed ID: 15118537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sepsis and septic shock.
    Zanetti G; Baumgartner JD; Glauser MP
    Schweiz Med Wochenschr; 1997 Mar; 127(12):489-99. PubMed ID: 9106949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic biomarkers for human sepsis and septic shock: insights from immunosuppression.
    Beltrán-García J; Osca-Verdegal R; Romá-Mateo C; Carbonell N; Ferreres J; Rodríguez M; Mulet S; García-López E; Pallardó FV; García-Giménez JL
    Epigenomics; 2020 Apr; 12(7):617-646. PubMed ID: 32396480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The safety and efficacy of the use of vasopressin in sepsis and septic shock.
    Wilson SJ; Mehta SS; Bellamy MC
    Expert Opin Drug Saf; 2005 Nov; 4(6):1027-39. PubMed ID: 16255662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.